Org.nr 936 656 013 2023 → 2024 Year-over-year analysis

MEDISTIM ASA: årsregnskap 2024 vs 2023

Fresh owner capital

approved 2025-05-08; registry 2025-06-07; journal 2025 481690

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2024 with 2023 for MEDISTIM ASA. Revenue 341.0k NOK → 354.0k NOK (+3.8%). Net result +99.45m NOK → +103.31m NOK. Equity 214.8k NOK → 209.19m NOK.

On the constructive side: revenue rose; operating result improved; equity strengthened.

Also worth watching: payroll increased; cogs fell; book investments changed. All figures are taken from the published annual accounts for MEDISTIM ASA.

Scorecard

Revenue
341.0k NOK 354.0k NOK
+3.8%
Operating result
+108.0k NOK +110.3k NOK
+2.1%
Net result
+99.45m NOK +103.31m NOK
+3.9%
Equity
214.8k NOK 209.19m NOK
+97264.6%
Cash
82.48m NOK 126.88m NOK
+53.8%
Total assets
402.2k NOK 466.7k NOK
+16.0%

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 341.0k NOK to 354.0k NOK (+3.8% YoY). Calculated

  • ↑

    Operating result improved

    Operating result +108.0k NOK → +110.3k NOK (op. margin 31.7% → 31.2%). Calculated

  • ↑

    Equity strengthened

    Book equity 214.8k NOK → 209.19m NOK (equity ratio 53.4% → 44819.7%). Calculated

  • ↑

    Cash rose

    Bank deposits 82.48m NOK → 126.88m NOK (+53.8% YoY). Calculated

  • ↑

    Current ratio back above 1×

    Current ratio 0.00× → 1.91×. Calculated

Things to notice

  • ·

    Payroll increased

    Salary cost 5 NOK → 21.19m NOK (0% → 5984% of revenue). Calculated

  • ·

    COGS fell

    COGS / varekostnad 66.58m NOK → 3.11m NOK (-95.3% YoY). Calculated

  • ·

    Book investments changed

    Investment / intangible book value 51.69m NOK → 51.16m NOK. Reported fact